Table 5.

Outcomes reported. Data are presented as median (range) or as reported.

Outcomes reported	Hip stems	Hip cups	Knees	All
n	63	34	54	151
All-cause revision	81%	67.6%	70.4%	74.2%
n revisions reported	4.5 (0–440)	1.5 (0–440)	3 (0–437)	4 (0–440)
Time-to-event analysis (95% CI)	25.4%	29.4%	33.3%	29.1%
PROs	23.8%	44.1%	46.3%	36.4%
Imaging	77.8%	85.3%	55.6%	71.5%
RSA study	8.3%	5.9%	9.3%	7.3%
Functional measures	1.6%	2.9%	59.3%	22.5%
Complications (excl. revision)	79.4%	73.5%	66.7%	73.5%
Reported complications %
Prosthesis infection (%)
Mean	0.9	0.5	0.6	0.7
Median (range)	0.8 (0–2.4)	0.1 (0–2.9)	0.4 (0–2.1)	0.7 (0–2.9)
Dislocation (%)
Mean	1.5	5.5	0	2.2
Median (range)	0.9 (0–8.2)	1.0 (0–100)	0 (0–0.4)	0 (0–100)
Fracture (%)
Mean	8.3	1.3	0.2	4.4
Median (range)	1.6 (0–100)	1.1 (0–4.4)	0 (0–1.8)	0.5 (0–100)
Thromboembolic event (%)
Mean	2.5	1.6	1.0	1.9
Median (range)	1.9 (0–8)	0 (0–4.7)	0.2 (0–4.8)	1.4 (0–8)
Myocardial infarction (%)
Mean	0.3	0	0	0.2
Median (range)	0 (0–1.2)	0 (0)	0 (0)	0 (0–1.2)
‘Concern’ reported in study
No concern expressed	87.3%	82.4%	90.7%	87.4%
Potential	4.8%	11.7%	7.4%	7.3%
Yes	7.9%	5.9%	1.9%	5.3%
‘Concern’ yes/potential based on
Imaging	38%	78%	0%	46%
Revision	25%	11%	60%	27%
PROs	0%	0%	40%	9%
Other	38%	11%	0%	18%

PROs, patient-reported outcomes; RSA, radiostereometric analysis.